Treatment Registry
TR-0422 ActiveRecorded September 2026Last verified October 2026

Semaglutide

Sold by AbundRX · every semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPublished rateCharged today
Semaglutide-based care starting figure; billing period unknown

Price conditions have not been established; the quoted figure is not a verified recurring rate.

Prescription and individual eligibility required. This published figure does not establish a full payable invoice, payment interval or automatic renewal.

“Programs begin at $99 for semaglutide-based care and $149 for tirzepatide-based care. Pricing is designed to be straightforward and may include provider review, care planning, follow-up support, and medication fulfillment if prescribed.”

$99Published figureCharged todayNot verified
Price sources
Visit AbundRX

We earn nothing from this link. It opens AbundRX's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberNot disclosed
CancellationThe refund page makes prescription sales final after payment is charged and the package is handed to a carrier, with no medication returns after dispensing. Cancellation requests are required at least 72 hours before the next billing date to stop that cycle; later requests take effect subsequently. The shipping policy separately says medication not shipped within 14 days of order permits a refund request regardless of medical-review status, with support review and processing when applicable. Lost/damaged shipments should be reported for assistance/reshipment; the thirty-day unopened OTC return policy is not a prescription return entitlement. https://abundantwellness.co/refund https://abundantwellness.co/shippingpolicy
MembershipNot disclosed
Consult feeNot disclosed

Recorded from abundantwellness.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Candidate list names this company 'AbundRX' but the domain is abundantwellness.co; the site's own hero text confirms identity ('AbundRX is Proud to be LegitScript Certified'). Pricing language is hedgy throughout ('may include ... medication fulfillment if prescribed') and a banner separately advertises 'Unlock Premium Access — $99 with Fast, Free Shipping', which reads like an access fee rather than a medication price. The FAQ, however, directly ties the $99/$149 figures to the semaglutide- and tirzepatide-based care options as the starting cost of the program, not a fee that explicitly excludes medication (no 'medication billed separately' language found), so these are recorded as prices rather than a membership — but the ambiguity itself is worth flagging. No state-coverage statement found anywhere checked.
  2. 2. October 2026 — The public catalog names semaglutide-based and tirzepatide-based care, but does not establish a brand, an unconditional compounded formulation or a specific dosage form for either current program. Its compounded-medication statement is conditional. The pages discuss once-weekly treatment, but do not specify the currently supplied dosage form or device. https://abundantwellness.co/
  3. 3. October 2026 — Starting care prices may include provider review, planning, follow-up and medication fulfillment if prescribed, with final pricing dependent on clinical review. The separate premium-access headline is not enough to establish a required membership or that medication is always included. The published pages do not specify a billing period, complete payable invoice or separate consultation charge. https://abundantwellness.co/
  4. 4. October 2026 — No named pharmacy or affirmative state roster is established. Terms allow patients to request a pharmacy of their choosing; that is not a named dispensing assignment. Shipping policy says state regulations determine whether review requires an online consultation; it does not resolve live versus asynchronous modality. https://abundantwellness.co/terms https://abundantwellness.co/shippingpolicy

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0422
Medication category
semaglutide
Readings
2

Related records

Cite this entry

Treatment Registry. (2026). AbundRX — semaglutide (TR-0422). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0422

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.